SCHEMBL3524135

SCHEMBL3524135

NNC(=O)CNC(=O)NCc1ccco1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.63
TDP1 Q9NUW8 1/20 0.61
GAA P10253 3/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 4/20 0.55
MAPT P10636 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
KDM4E B2RXH2 1/20 0.52
POLB P06746 1/20 0.52
PTPN7 P35236 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
RAB9A P51151 1/20 0.52
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31556343 0.85 EPHX2 (0.68) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL24575916 0.85 EPHX2 (0.83) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL5125065 0.78 EPHX2 (0.71) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL23012354 0.77 EPHX2 (0.60) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL29410065 0.77 ALDH1A1 (0.74) EPHX2TDP1KMT2AALDH1A1MAPT
SCHEMBL15224222 0.76 EPHX2 (0.72) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL15224223 0.76 EPHX2 (0.82) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL14511323 0.76 ALDH1A1 (0.68) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL16622593 0.76 EPHX2 (0.68) EPHX2TDP1GAAKMT2AALDH1A1
SCHEMBL2755805 0.76 EPHX2 (0.68) EPHX2TDP1GAAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696231-B2 Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2010-04-13 US disclosed
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 2005-02-24 US disclosed
EP-1439834-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) Applied Research Systems ARS Holding N.V. (AN) 2004-07-28 EP disclosed
WO-2003037328-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) PTPRO, PTPRE, PTPRZ1 EPHX2 2888/4885TDP1 1267/4885GAA 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.